ACTIVE

HUMAN PHARMA

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
46,8 k €
-44.8% YoY
Gross margin
114,6 k €
-29.3% YoY
Equity
224,8 k €
+26.3% YoY
Workforce
0,8 ETP
+14.3% YoY

What does HUMAN PHARMA do?

HUMAN PHARMA is a Private limited company incorporated in 2023. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Charleroi. It employs on average 0,8 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0800.381.939
Incorporation
04/04/2023
Legal form
Private limited company
Registered office
Rue du Sanatorium 36
6001 Charleroi · WallonieSee on map
Contributed capital
3 000,00 €
Latest accounts
31/12/2025
Average workforce
0,8 ETP
Activities (NACE)
47730Dispensing chemist in specialised stores· main47730Dispensing chemist in specialised stores21100Manufacture of basic pharmaceutical products21100Manufacture of basic pharmaceutical products47740Retail sale of medical and orthopaedic goods in specialised stores47741Retail sale of medical and orthopaedic goods in specialised stores+2
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 3 financial years

202520242023
Income statement
Gross margin114,6 k €162 k €167,8 k €
EBITDA79,4 k €125,2 k €129,8 k €
Operating result65,9 k €112,6 k €120,5 k €
Net result46,8 k €84,8 k €90,3 k €
Balance sheet
Equity224,8 k €178 k €93,3 k €
Total assets434,1 k €538,4 k €208,9 k €
Cash7,8 k €15 k €16,3 k €
Debts209,3 k €351,4 k €106,6 k €
Other
Workforce0,8 ETP0,7 ETP36 816,1 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 1 ended

Active mandates

SERGE AIME NGANDEU NGONLEBEK

Director · since 30 mars 2023

Active

Ended mandates

Serge Ngandeu Ngonlebek

Director · since 30 mars 2023

Ended
Annual accounts

Full financial information

202520242023
Type of accountAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/2023
Closing of the financial year31/12/202531/12/202431/12/2023
Length of the financial year12 months12 months12 months
Filing date31/08/202608/11/202516/07/2025
General meeting26/06/202627/06/202529/04/2025
Currency of the financial yearEUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

4 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202526/06/202631/08/2026FrenchPDF
Abridged model31/12/202427/06/202508/11/2025FrenchPDF
Abridged modelCorrection31/12/202329/04/202516/07/2025FrenchPDF
Abridged model31/12/202328/06/202404/11/2024FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 1 ended

Active mandates

SERGE AIME NGANDEU NGONLEBEK

Director · since 30 mars 2023

Active

Ended mandates

Serge Ngandeu Ngonlebek

Director · since 30 mars 2023

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Other06/04/2023
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202546,8 k €↓
  2. 2024
    Annual accounts 202484,8 k €↓
  3. 2023
    Annual accounts 202390,3 k €
  4. 04/04/2023
    IncorporationPrivate limited company